Widely predicting specific protein functions based on protein-protein interaction data and gene expression profile

2007 ◽  
Vol 50 (1) ◽  
pp. 125-134 ◽  
Author(s):  
Lei Gao ◽  
Xia Li ◽  
Zheng Guo ◽  
MingZhu Zhu ◽  
YanHui Li ◽  
...  
2005 ◽  
Vol 03 (06) ◽  
pp. 1371-1389 ◽  
Author(s):  
GUANGHUA XIAO ◽  
WEI PAN

Prediction of biological functions of genes is an important issue in basic biology research and has applications in drug discoveries and gene therapies. Previous studies have shown either gene expression data or protein-protein interaction data alone can be used for predicting gene functions. In particular, clustering gene expression profiles has been widely used for gene function prediction. In this paper, we first propose a new method for gene function prediction using protein-protein interaction data, which will facilitate combining prediction results based on clustering gene expression profiles. We then propose a new method to combine the prediction results based on either source of data by weighting on the evidence provided by each. Using protein-protein interaction data downloaded from the GRID database, published gene expression profiles from 300 microarray experiments for the yeast S. cerevisiae, we show that this new combined analysis provides improved predictive performance over that of using either data source alone in a cross-validated analysis of the MIPS gene annotations. Finally, we propose a logistic regression method that is flexible enough to combine information from any number of data sources while maintaining computational feasibility.


2021 ◽  
Author(s):  
Chunyang Wang ◽  
Shiwei Liao ◽  
jing xu

Abstract In this study, we developed a computational method to identify Guillain–Barré syndrome (GBS) related genes based on (i) a gene expression profile, and (ii) the shortest path analysis in a protein-protein interaction (PPI) network. The mRMR (Maximum Relevance Minimum Redundancy) method was employed to select significant genes from an mRNA profile dataset of GBS patients and healthy controls. The protein products of the significant genes were then mapped to a PPI network generated from the STRING database. Shortest paths were computed and all shortest path proteins were picked out and were ranked according to their betweenness. Related genes of the top-most proteins in the ordered list were then retrieved and were regarded as potential GBS related genes in this study. As a result, totally 30 GBS related genes were screened out, in which 20 were retrieved from PPI analysis of up-regulated expressed genes and 23 were from down-regulated expressed genes (13 overlap genes). GO enrichment and KEGG enrichment analysis were performed respectively. Results showed that there were some overlap GO terms and KEGG pathway terms in both up-regulated and down-regulated analysis, which indicated these terms may play critical role during GBS process. These results could shed some light on the understanding of the Genetic and molecular pathogenesis of GBS disease, providing basis for future experimental biology studies and for the development of effective genetic strategies for GBS clinical therapies.


2021 ◽  
Author(s):  
Chunyang Wang ◽  
Shiwei Liao ◽  
Xiaowei Hu ◽  
Jing Xu

Abstract Background In this study, we developed a computational method to identify Guillain–Barré syndrome (GBS) related genes based on (i) a gene expression profile, and (ii) the shortest path analysis in a protein-protein interaction (PPI) network. Results Totally 30 GBS related genes were screened out, in which 20 were retrieved from PPI analysis of up-regulated expressed genes and 23 were from down-regulated expressed genes (13 overlap genes). GO enrichment and KEGG enrichment analysis were performed respectively. Results showed that there were some overlap GO terms and KEGG pathway terms in both up-regulated and down-regulated analysis, which indicated these terms may play critical role during GBS process. Discussion These results could shed some light on the understanding of the Genetic and molecular pathogenesis of GBS disease, providing basis for future experimental biology studies and for the development of effective genetic strategies for GBS clinical therapies.


Sign in / Sign up

Export Citation Format

Share Document